DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV	MAPPED_TRAIT	MAPPED_TRAIT_URI	STUDY ACCESSION	GENOTYPING TECHNOLOGY
2012-07-19	22664479	Han JY	2012-06-05	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/22664479	A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell lung cancer.	Response to irinotecan in non-small-cell lung cancer	101 non-small-cell lung cancer cases	146 non-small-cell lung cancer cases	8q13.2	8	68476982	C8orf34	C8orf34			116328			rs1517114-C	rs1517114	0	1517114	intron_variant	0	0.12	9E-6	5.045757490560675	(G3D)	4.1	[2.10-8.00]	Affymetrix [312230]	N	response to irinotecan, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004829, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001558	Genome-wide genotyping array
2012-07-19	22664479	Han JY	2012-06-05	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/22664479	A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell lung cancer.	Response to irinotecan in non-small-cell lung cancer	101 non-small-cell lung cancer cases	146 non-small-cell lung cancer cases	20p12.3	20	8297296	PLCB1	PLCB1			23236			rs2745761-C	rs2745761	0	2745761	intron_variant	0	0.072	6E-6	5.221848749616356	(G3D)	4.8	[2.30-10.0]	Affymetrix [312230]	N	response to irinotecan, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004829, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001558	Genome-wide genotyping array
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	1p31.3	1	67639770	intergenic	LOC105378780 - HNRNPCP9	105378780	100130196		49350	2943	rs344924-?	rs344924	0	344924	intergenic_variant	1	NR	3E-7	6.522878745280337	(Recessive model)	4.9	[2.70-9.0]	Affymetrix [334127]	N	response to irinotecan, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004829, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001901	Genome-wide genotyping array
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	2p24.1	2	19429543	intergenic	LOC101928196			101928196			rs13398721-?	rs13398721	0	13398721	intergenic_variant	0	NR	2E-7	6.698970004336019	(Recessive model)	7.1	[3.40-14.70]	Affymetrix [334127]	N	response to irinotecan, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004829, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001901	Genome-wide genotyping array
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	6q22.1	6	117450114	DCBLD1	RAP1BP3 - RNU6-253P	100132917	106480697		18061	7620	rs17635492-?	rs17635492	0	17635492	intron_variant	1	NR	4E-7	6.3979400086720375	(Dominant model)	7.6	[3.50-16.70]	Affymetrix [334127]	N	response to irinotecan, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004829, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001901	Genome-wide genotyping array
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	7p14.3	7	28974579	intergenic	TRIL - LOC100506497	9865	100506497		16166	5388	rs2018683-T	rs2018683	0	2018683	regulatory_region_variant	1	NR	8E-7	6.096910013008056	(Recessive model)	7.8	[3.4-17.7]	Affymetrix [334127]	N	response to irinotecan, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004829, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001901	Genome-wide genotyping array
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	13q32.1	13	95123178	ABCC4	ABCC4			10257			rs16950650-T	rs16950650	0	16950650	intron_variant	0	NR	2E-7	6.698970004336019	(Dominant model)	30.2	[8.4-109.0]	Affymetrix [334127]	N	response to irinotecan, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004829, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001901	Genome-wide genotyping array
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	14q32.13	14	95476110	C14orf49	SYNE3			161176			rs11622887-?	rs11622887	0	11622887	intergenic_variant	0	NR	3E-7	6.522878745280337	(Recessive model)	3.5	[2.20-5.60]	Affymetrix [334127]	N	response to irinotecan, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004829, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001901	Genome-wide genotyping array
2013-07-01	23478653	Han JY	2013-03-12	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/23478653	A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.	Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	139 individuals	NA	16p12.3	16	16864058	intergenic	LOC100133127 - LOC441750	100133127	441750		322223	88445	rs7186128-G	rs7186128	0	7186128	intergenic_variant	1	NR	4E-7	6.3979400086720375	(Additive model)	2.5	[1.70-3.50]	Affymetrix [334127]	N	response to irinotecan, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004829, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001901	Genome-wide genotyping array
